Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of immunological synapse formation. [GOC:obol]
Positive regulation of immunological synapse formation is a complex and tightly regulated process that is essential for adaptive immune responses. It involves a series of molecular interactions between immune cells, primarily T lymphocytes and antigen-presenting cells (APCs), leading to the formation of a specialized cell-cell junction called the immunological synapse. This synapse serves as a platform for the delivery of signals that activate T cells and initiate downstream signaling pathways, ultimately leading to the generation of an effective immune response.
The process begins with the recognition of antigen by the T cell receptor (TCR) on the surface of the T cell. This recognition event triggers a series of intracellular signaling events that lead to the activation of various signaling molecules, including kinases, phosphatases, and adaptor proteins. These signaling molecules initiate a cascade of events that ultimately result in the polarization of the T cell cytoskeleton and the recruitment of specific molecules to the site of contact between the T cell and the APC.
One of the key events in the formation of the immunological synapse is the clustering of TCRs and other signaling molecules into a central supramolecular activation cluster (cSMAC). This clustering is mediated by interactions between TCRs, coreceptors, and various adaptor proteins. The cSMAC serves as a signaling hub that amplifies and sustains TCR-mediated signaling.
Simultaneously, other molecules, including adhesion molecules and cytoskeletal components, are recruited to the periphery of the synapse, forming a peripheral supramolecular activation cluster (pSMAC). The pSMAC provides structural support to the synapse and ensures the stability of the T cell-APC interaction.
As the synapse matures, the T cell undergoes a profound reorganization of its cytoskeleton. Actin filaments are reorganized, forming a ring-like structure around the synapse, which provides structural support and facilitates the delivery of signaling molecules to the cSMAC. The microtubule network is also polarized, with microtubules extending from the centrosome towards the synapse, providing a track for the transport of vesicles containing signaling molecules and other essential components.
The formation and maturation of the immunological synapse is a dynamic process that is constantly regulated by a complex interplay of signaling pathways. The strength and duration of TCR signaling, the availability of adhesion molecules, and the cytoskeletal dynamics all contribute to the stability and function of the synapse.
The positive regulation of immunological synapse formation is essential for the initiation and propagation of immune responses. Dysregulation of this process can lead to impaired T cell activation and defective immune responses. Conversely, uncontrolled synapse formation can contribute to the development of autoimmune diseases. Therefore, understanding the molecular mechanisms underlying the regulation of immunological synapse formation is critical for developing new therapeutic strategies for a variety of immune disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
C-C chemokine receptor type 7 | A C-C chemokine receptor type 7 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P32248] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
tak 779 | |||
cenicriviroc | cenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH). cenicriviroc: an inhibitor of HIV-1 | aromatic ether; benzazocine; diether; imidazoles; secondary carboxamide; sulfoxide | anti-HIV agent; anti-inflammatory agent; antirheumatic drug; chemokine receptor 2 antagonist; chemokine receptor 5 antagonist |